Drug Study Aldomet Methyldopa w/Nursing Responsibilities

Generic    Brand                 Dosage                Action              C.I.              Side Eff.    Nsg. Resp

Methyldopa

Aldomet

Adults: 250-500mg PO bid-tid or 250mg-1g IV

Centrally acting antihypertensive, decreases sympathetic outflow

Liver Disease, bisulfate allergy

Discolors urine, initial transient sedation, edema, hemolytic anemia, hepatic disorders, fevers,

Tolerance may occur, Monitor hepatic function, especially in the first 6---12 wk of therapy or if unexplained fever appears. Discontinue drug if fever, abnormalities in liver function tests, or jaundice occur. Discontinue therapy if involuntary choreoathetotic movements occur. Discontinue if edema progresses or signs of CHF occur.